These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 17287408

  • 1. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
    Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Kaprara A, Blakeman J, Vainas I, Mpousoulegas A, Williams CJ, Mantzoros C.
    Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA, Borofsky ND, Massardo S, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [Abstract] [Full Text] [Related]

  • 3. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [Abstract] [Full Text] [Related]

  • 4. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 5. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES, Holly JM, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 7. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA.
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
    [Abstract] [Full Text] [Related]

  • 9. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [Abstract] [Full Text] [Related]

  • 10. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [Abstract] [Full Text] [Related]

  • 11. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ, Guevara-Aguirre J, Rosenbloom AL, Carlsson L, Hintz RL, Rosenfeld RG.
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [Abstract] [Full Text] [Related]

  • 12. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H, Flyvbjerg A, Mellemkjaer L, Tjønneland A, Christensen J, Sørensen HT, Overvad K.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [Abstract] [Full Text] [Related]

  • 13. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.
    Diabetes Metab Res Rev; 1999 Nov; 15(5):314-22. PubMed ID: 10585616
    [Abstract] [Full Text] [Related]

  • 14. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH.
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [Abstract] [Full Text] [Related]

  • 15. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
    Olivecrona H, Hilding A, Ekström C, Barle H, Nyberg B, Möller C, Delhanty PJ, Baxter RC, Angelin B, Ekström TJ, Tally M.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
    [Abstract] [Full Text] [Related]

  • 16. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG, Ropelato MG, Domené HM, Pennisi P, Heinrich JJ, Jasper HG.
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [Abstract] [Full Text] [Related]

  • 17. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
    Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE.
    Cancer Res; 2000 Jul 15; 60(14):3744-8. PubMed ID: 10919644
    [Abstract] [Full Text] [Related]

  • 18. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, Rinaldi S, Riboli E, Seidell JC, Grobbee DE, Peeters PH.
    Int J Cancer; 2003 Aug 10; 106(1):90-5. PubMed ID: 12794762
    [Abstract] [Full Text] [Related]

  • 19. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R, Lange KH, Kjaer M, Jørgensen JO, Christiansen JS, Orskov H, Flyvbjerg A.
    J Clin Endocrinol Metab; 2001 Feb 10; 86(2):669-74. PubMed ID: 11158029
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, Baylink DJ, Mohan S, Chihara K, Sugimoto T.
    Calcif Tissue Int; 2006 Jan 10; 78(1):18-24. PubMed ID: 16397738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.